Action Point Financial Planning’s Iovance Biotherapeutics IOVA Stock Holding History

Action Point Financial Planning’s Portfolio IOVA Stock Details IOVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8.01K	Buy	+1,926	New	+$7.32K	﹤0.01%	1566

Other funds holding IOVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

MFM

MHR Fund Management New York $1.92B AUM 119.57% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

Action Point Financial Planning's IOVA Position: Q2 2026 in Review

Action Point Financial Planning opened a new position in Iovance Biotherapeutics (IOVA) in Q2 2026: 1,926 shares worth $8.01K. The stake represents ﹤0.01% of the portfolio and ranks #1566 among its holdings.

288 funds tracked by Wall St. Rank hold IOVA as of Q2 2026.

Action Point Financial Planning held 1,926 shares of Iovance Biotherapeutics worth $8.01K as of Q2 2026.
Iovance Biotherapeutics was a new Action Point Financial Planning position in Q2 2026.
Iovance Biotherapeutics made up ﹤0.01% of Action Point Financial Planning's portfolio in Q2 2026, its #1566 holding.
288 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q2 2026.

Based on Action Point Financial Planning's 13F filing for Q2 2026, filed 14 Aug 2026.